Compounds > ru-66647

ru-66647 and Liver-Failure--Acute

ru-66647 has been researched along with Liver-Failure--Acute* in 3 studies

Other Studies

3 other study(ies) available for ru-66647 and Liver-Failure--Acute

ArticleYear
The FDA and the case of Ketek.
    The New England journal of medicine, 2007, Apr-19, Volume: 356, Issue:16

    Topics: Advisory Committees; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Approval; Humans; Ketolides; Liver Failure, Acute; Patient Selection; Scientific Misconduct; United States; United States Food and Drug Administration

2007
A fine pile of paté: the cautionary tale of telithromycin, hepatic failure, and study 3014.
    Surgical infections, 2006, Volume: 7, Issue:3

    Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Fraud; Humans; Ketolides; Liver Failure, Acute; United States; United States Food and Drug Administration

2006
Telithromycin and acute liver failure.
    The New England journal of medicine, 2006, Nov-23, Volume: 355, Issue:21

    Topics: Anti-Bacterial Agents; Asthma; Bacterial Infections; Drug Approval; Humans; Ketolides; Liver Failure, Acute; Product Surveillance, Postmarketing; United States; United States Food and Drug Administration

2006